Evidence map›Paper›PMID 37623751›Full record

ArticleMembranes2023

Improvement of MBBR-MBR Performance by the Addition of Commercial and 3D-Printed Biocarriers.

Dimitra C Banti, Petros Samaras, Eleni Kostopoulou, Vassiliki Tsioni, Themistoklis Sfetsas

Open access · goldAbstract read
In one paragraph

Article in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dimitra C BantiQLAB Private Company, Research & Development, Quality Control and Testing Services, 57008 Thessaloniki, Greece.ORCID 0000-0001-5318-1974
Petros SamarasDepartment of Food Science and Technology, School of Geotechnical Sciences, International Hellenic University, 57400 Thessaloniki, Greece.ORCID 0000-0002-4081-8590
Eleni KostopoulouQLAB Private Company, Research & Development, Quality Control and Testing Services, 57008 Thessaloniki, Greece.
Vassiliki TsioniQLAB Private Company, Research & Development, Quality Control and Testing Services, 57008 Thessaloniki, Greece.
Themistoklis SfetsasQLAB Private Company, Research & Development, Quality Control and Testing Services, 57008 Thessaloniki, Greece.ORCID 0000-0002-9020-2719
Qlab Analytical Laboratory (Greece)International Hellenic University · GR

Funding

This research was co-funded by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH-CREATE-INNOVATE. T2EDK-00362
6 · The paper itself

Abstract

Moving bed biofilm reactor combined with membrane bioreactor (MBBR-MBR) constitute a highly effective wastewater treatment technology. The aim of this research work was to study the effect of commercial K1 biocarriers (MBBR-MBR K1 unit) and 3D-printed biocarriers fabricated from 13X and Halloysite (MBBR-MBR 13X-H unit), on the efficiency and the fouling rate of an MBBR-MBR unit during wastewater treatment. Various physicochemical parameters and trans-membrane pressure were measured. It was observed that in the MBBR-MBR K1 unit, membrane filtration improved reaching total membrane fouling at 43d, while in the MBBR-MBR 13X-H and in the control MBBR-MBR total fouling took place at about 32d. This is attributed to the large production of soluble microbial products (SMP) in the MBBR-MBR 13X-H, which resulted from a large amount of biofilm created in the 13X-H biocarriers. An optimal biodegradation of the organic load was concluded, and nitrification and denitrification processes were improved at the MBBR-MBR K1 and MBBR-MBR 13X-H units. The dry mass produced on the 13X-H biocarriers ranged at 4980-5711 mg, three orders of magnitude larger than that produced on the K1, which ranged at 2.9-4.6 mg. Finally, it was observed that mostly extracellular polymeric substances were produced in the biofilm of K1 biocarriers while in 13X-H mostly SMP.

Indexed as

13X-halloysite biocarriers3D-printed biocarriersbiofilmcolloidal particlesEPSKaldnes K1 biocarriersMBBR-MBRmembrane foulingSMPwastewater treatment

Identifiers

PMID37623751
PMCPMC10456846
OpenAlexW4385254939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.